References
- HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
- GershonASWarnerLCascagnettePVictorJCToTLifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population studyLancet2011378979599121907862
- ParkTSLeeJSSeoJBPhenotyping of chronic obstructive pulmonary disease: heterogeneity and its clinical relevanceCurr Respir Care Rep201213189198
- Chorostowska-WynimkoJDisease modification in emphysema related to alpha-1 antitrypsin deficiencyCOPD201613680781527172295
- Pinto-PlataVTosoJLeeKUse of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parametersProc Am Thorac Soc20063646546616921105
- GrayRDMacGregorGNobleDSputum proteomics in inflammatory and suppurative respiratory diseasesAm J Respir Crit Care Med2008178544445218565957
- MerkelDRistWSeitherPWeithALenterMCProteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identificationProteomics20055112972298016075419
- LeeEJInKHKimJHProteomic analysis in lung tissue of smokers and COPD patientsChest2009135234435218753468
- AdamkoDJNairPMayersITsuyukiRTRegushSRoweBHMetabolomic profiling of asthma and chronic obstructive pulmonary disease: a pilot study differentiating diseasesAllergy Clin Immunol20151363571580
- MagdeldinSHiraoYElguoshyAA proteomic glimpse into human ureter proteomeProteomics2016161808426442468
- BrownCEMcCarthyNSHughesADUrinary proteomic biomarkers to predict cardiovascular eventsProteomics Clin Appl201595–661061725786980
- BrebnerJAStockleyRARecent advances in α-1-antitrypsin deficiency-related lung diseaseExpert Rev Respir Med2013721372923734645
- HuangJTChaudhuriRAlbarbarawiOClinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary diseaseThorax201267650250822250098
- LiuXMaSLiuSLiuMTurinoGCantorJThe ratio of free to bound desmosine and isodesmosine may reflect emphysematous changes in COPDLung2015193332933425762453
- MischakHCoonJJNovakJWeissingerEMSchanstraJPDominiczakAFCapillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developmentsMass Spectrom Rev200928570372418973238
- WuJGaoYPhysiological conditions can be reflected in human urine proteome and metabolomeExpert Rev Proteomics201512662363626472227
- KistlerADSerraALSiwyJUrinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric studyPLoS One201381e5301623326375
- MischakHKolchWAivaliotisMComprehensive human urine standards for comparability and standardization in clinical proteome analysisProteom Clin Appl201044464478
- TheodorescuDWittkeSRossMMDiscovery and validation of new protein biomarkers for urothelial cancer: a prospective analysisLancet Oncol20067323024016510332
- NeuhoffNKaiserTWittkeSMass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometryRapid Commun Mass Spectrom200418214915614745763
- DaknaMHeZYuWCMischakHKolchWTechnical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessmentJ Chromatogr B Analyt Technol Biomed Life Sci20098771312501258
- MischakHVlahouAIoannidisJPTechnical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experienceClin Biochem201346643244323041249
- ReimandJArakTAdlerPg:Profiler-a web server for functional interpretation of gene lists (2016 update)Nucleic Acids Res201644W1W83W8927098042
- KucichUChristnerPLippmannMImmunologic measurement of elastin-derived peptides in human serumAm Rev Respir Dis19831272S28S30
- WendtCHNelsestuenGHarveySGulcevMStoneMReillyCPeptides in bronchoalveolar lavage in chronic obstructive pulmonary diseasePLoS One2016115e015572427227774
- JanciauskieneSWelteTWell-Known and less well-known functions of alpha-1 antitrypsin. Its role in chronic obstructive pulmonary disease and other disease developmentsAnn Am Thorac Soc201613 Suppl 4S280S28827564662
- StockleyRABurnettDControversy about alpha 1-antitrypsin in bronchoalveolar lavage fluidsLancet1983283621311
- TurinoGMMaSLinYYCantorJOLuisettiMMatrix elastin: a promising biomarker for chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201118463764121757624
- ShamamianPSchwartzJDPocockBJActivation of progelati-nase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesisJ Cell Physiol2001189219720611598905
- StolkJSeersholmNKalshekerNAlpha1-antitrypsin deficiency: current perspective on research, diagnosis, and managementInt J Chron Obstruct Pulmon Dis20061215116018046892
- HuertasAPalangePCOPD: a multifactorial systemic diseaseTher Adv Respir Dis20115321722421429981
- OikonomouNThanasopoulouATzouvelekisAGelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosisThorax200964646747519213772
- BortnerJDJrRichieJPJrDasALiaoJProteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smokingJ Proteome Res20111031151115921186835
- TangJRamnathNMoysichKBPrognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancerBMC cancer2006620316882345
- HuangBDengSLooSYGelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinomaOncotarget2016718253912540727058427
- HoriguchiMOisoYSakaiHMotomuraTYamashitaCPulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regenerationJ Control Release201521311211926160307
- KimMNLeeKEHongJYInvolvement of the MAPK and PI3K pathways in chitinase 3-like 1-regulated hyperoxia-induced airway epithelial cell deathBiochem Biophys Res Commun2012421479079622554524
- KimCLeeJMParkSWAttenuation of cigarette smoke-induced emphysema in mice by apolipoprotein A-1 overexpressionAm J Respir Cell Mol Biol20165419110226086425
- MorenoJAOrtega-GomezARubio-NavarroAHigh-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysemaAm J Respir Cell Mol Biol20145153654924787644
- GordonEMFigueroaDMBarochiaAVYaoXLevineSJHigh-density lipoproteins and apolipoprotein A-I: potential new players in the prevention and treatment of lung diseaseFront Pharmacol2016732327708582
- NicholasBLSkippPBartonSIdentification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181101049106020110559
- JinQChenYLouYHeXLow Serum retinol-binding protein-4 levels in acute exacerbations of chronic obstructive pulmonary disease at intensive care unit admission is a predictor of mortality in elderly patientsJ Inflamm201310131
- BidanCMVeldsinkACMeursHGosensRAirway and extracellular matrix mechanics in COPDFront Physiol2015634626696894
- VargheseSAPowellTBBudisavljevicMNUrine biomarkers predict the cause of glomerular diseaseJ Am Soc Nephrol200718391392217301191
- KwakNJHeoYJinDCProteomic analysis of alpha-1-antitrypsin in immunoglobulin A nephropathyProteomics Clin Appl20071442042821136694
- CandianoGMusanteLBruschiMRepetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndromeJ Am Soc Nephrol200617113139314817005933
- BlaurockNSchmerlerDHünnigerKC-Terminal alpha-1 antitrypsin peptide: a new sepsis biomarker with immunomodulatory functionMediators of Inflammation20162016612943727382189
- SchanstraJPMischakHProteomic urinary biomarker approach in renal disease: from discovery to implementationPediatr Nephrol201530571372524633400
- CaneJLMallia-MillanesBForresterDLKnoxAJBoltonCEJohnsonSRMatrix metalloproteinases-8 and -9 in the airways, blood and urine during exacerbations of COPDCOPD2016131263426418236